risk factors for fracture in postmenopausal osteoporosis
Last reviewed 01/2018
As well as increasing age and low bone mineral density (BMD), many other factors can determine the risk of fracture.
Risk factors for fracture in postmenopausal osteoporosis
- Independent clinical risk factors for fracture:
- Parental history of hip fracture
- Alcohol intake of 4 or more units a day
- Prior fracture
- Rheumatoid arthritis (RA)
- Indicators of low BMD:
- Low body mass index (BMI) (<22kg/m2)
- Medical conditions e.g. ankylosing spondylitis, Crohn's disease, RA
- Conditions that result in prolonged immobility
- Untreated premature menopause
Reference:
- 1) NICE. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. Technology Appraisal 160. October 2008
- 2) NICE. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Technology Appraisal 161. October 2008